Gersten D M, Williams L J, Moody D, Montague P M, Law L W, Hearing V J
Department of Pathology, Georgetown University Medical Center, DC 20007.
Int J Cancer. 1989 Mar 15;43(3):497-500. doi: 10.1002/ijc.2910430326.
B700 and B50 are melanoma-specific antigens originally isolated from B16 murine melanoma. B700, which elicits a strong tumor rejection response, is present on all murine melanomas tested to date. We now demonstrate the presence of B50 in the other murine melanomas and find that the 2 molecules are non-covalently complexed with each other within the cells. We also show that hosts immunized with intact, irradiated melanoma cells produce antibodies that specifically recognize the B700 and B50 tumor antigens. These results suggest that B50 may also participate in the host response to melanoma growth.
B700和B50是最初从B16小鼠黑色素瘤中分离出的黑色素瘤特异性抗原。B700能引发强烈的肿瘤排斥反应,迄今在所有测试的小鼠黑色素瘤中均有存在。我们现在证明了B50在其他小鼠黑色素瘤中的存在,并发现这两种分子在细胞内彼此非共价结合。我们还表明,用完整的、经辐射的黑色素瘤细胞免疫的宿主会产生特异性识别B700和B50肿瘤抗原的抗体。这些结果表明,B50也可能参与宿主对黑色素瘤生长的反应。